InvestSMART

ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD
Current share price for RMD : $32.185 0.385 (1.21%)+
Announcement
Release
14 Aug 2026 8:32AM
Price at Release
$31.800
Full Release
download
Summary
ResMed Inc.'s Form 10-K Annual Report for the fiscal year ended June 30, 2026, highlights a 10% increase in net revenue to $5,653 million compared to the previous fiscal year. The company's net income rose to $1,523 million, with a diluted earnings per share of $10.43. ResMed's growth was driven by increased demand for devices and masks within its Sleep and Breathing Health business, particularly in the Americas and Rest of World regions. The company's total assets reached $9 billion, and stockholders' equity was reported at $6.6 billion. ResMed also managed substantial cash flows, ending the year with $1.5 billion in cash and cash equivalents. A dividend of $0.60 per share was paid to shareholders during the fiscal year.
Key Points
  • Net revenue increased by 10% to $5,653 million.
  • Net income was $1,523 million with $10.43 diluted earnings per share.
  • Growth driven by increased demand for devices and masks.
  • Total assets at $9 billion, stockholders' equity at $6.6 billion.
  • Substantial cash flows with $1.5 billion in cash and equivalents.
  • Dividend of $0.60 per share paid to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.